Attention-deficit/hyperactivity disorder (ADHD) is a common but complex neurodevelopmental condition characterized by symptoms of inattention, hyperactivity, and ...

This graph visualizes how the trials included in the meta-analysis compared the effectiveness of different treatment strategies. The width of the lines connecting each treatment reflects the number of ...

The Prescription Drug User Fee Act target action date for the NDA is scheduled for 24 July 2026.

Feel like your brain is always on overdrive? Struggling to stay focused at work, forgetting things, jumping from one task to the next, or feeling like no matter how hard you try, you're always falling ...

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition that causes hyperactivity and impulsivity in children and adults. If left untreated ...

Axsome Therapeutics (NASDAQ:AXSM) announced Tuesday that solriamfetol, its experimental therapy for attention deficit hyperactivity disorder (ADHD), reached primary and secondary goals in a Phase 3 ...

He wrote the book, Unbreakable, to help others and erase stigma.

Are you or your loved one struggling with the overwhelming effects of trauma, PTSD, or substance abuse? Perhaps your child is facing challenges with ADHD, autism spectrum disorders, or behavioral ...

Boys who stopped ADHD treatment at higher risk for negative consequences. Oct. 16, 2012 — -- Young boys who discontinue treatment for attention deficit hyperactivity disorder (ADHD) are featured ...

In 2024, a BBC Freedom of Information request to the Essex Partnership University NHS Foundation Trust revealed 6,459 people ...

Children living in the lowest socioeconomic postcodes used to have the highest rates of ADHD prescriptions. But this has ...